- Investing Ideas
- /
- Taiwanese Biotech Stocks
Taiwanese Biotech Stocks
Results
53
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
53 companies
Caliway Biopharmaceuticals
Market Cap: NT$291.6b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$188.00
7D
-4.1%
1Y
213.3%
PharmaEssentia
Market Cap: NT$191.9b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$519.00
7D
6.8%
1Y
-9.3%
Bora Pharmaceuticals
Market Cap: NT$84.2b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$678.00
7D
-3.0%
1Y
8.5%
Lotus Pharmaceutical
Market Cap: NT$61.0b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$232.00
7D
21.1%
1Y
-13.3%
TTY Biopharm
Market Cap: NT$19.3b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$77.50
7D
1.2%
1Y
5.6%
Synmosa Biopharma
Market Cap: NT$15.8b
A specialty pharmaceutical company, researches, develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand in Taiwan.
4114
NT$34.60
7D
-1.7%
1Y
1.9%
ScinoPharm Taiwan
Market Cap: NT$15.2b
Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, India, the United States and internationally.
1789
NT$19.25
7D
1.9%
1Y
-23.8%
YungShin Global Holding
Market Cap: NT$15.1b
Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.
3705
NT$56.60
7D
1.6%
1Y
-7.7%
Tanvex BioPharma
Market Cap: NT$12.5b
A biopharmaceutical company, researches, develops, manufactures, and sells biosimilar products in Taiwan and the United States.
6541
NT$52.20
7D
5.5%
1Y
-23.5%
Acepodia
Market Cap: NT$10.4b
Operates as a clinical stage biotechnology company.
6976
NT$17.90
7D
5.9%
1Y
-25.4%
Standard Chemical & Pharmaceutical
Market Cap: NT$10.1b
Standard Chemical & Pharmaceutical Co. Ltd.
1720
NT$56.40
7D
1.8%
1Y
-12.6%
PharmaEngine
Market Cap: NT$9.7b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$67.40
7D
2.4%
1Y
-22.2%
Adimmune
Market Cap: NT$7.9b
Engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally.
4142
NT$18.70
7D
0.8%
1Y
-30.6%
Formosa Laboratories
Market Cap: NT$7.8b
Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.
4746
NT$64.90
7D
-2.4%
1Y
-33.8%
SCI Pharmtech
Market Cap: NT$7.2b
Together with its subsidiary, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals in Italy, the United States, Japan, Germany, Taiwan, Switzerland, China, and internationally.
4119
NT$60.00
7D
4.0%
1Y
-33.0%
OBI Pharma
Market Cap: NT$6.8b
A clinical stage oncology company, research and develops novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally.
4174
NT$25.95
7D
-1.9%
1Y
-64.6%
TaiGen Biopharmaceuticals Holdings
Market Cap: NT$6.4b
A pharmaceutical company, develops novel therapeutics for transformative diseases worldwide.
4157
NT$8.86
7D
1.0%
1Y
-38.9%
Sinphar PharmaceuticalLtd
Market Cap: NT$5.9b
Engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.
1734
NT$30.90
7D
1.3%
1Y
-0.8%
Savior Lifetec
Market Cap: NT$5.7b
A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.
4167
NT$17.90
7D
-0.8%
1Y
-16.0%
Orient Pharma
Market Cap: NT$5.7b
Engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.
4166
NT$25.40
7D
-2.3%
1Y
-1.6%
Cenra
Market Cap: NT$5.0b
Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.
3716
NT$33.90
7D
1.5%
1Y
-13.7%
StemCyte International
Market Cap: NT$4.7b
Operates cord blood cell banks in the United States and Taiwan.
4178
NT$24.40
7D
-3.2%
1Y
n/a
SunWay Biotech
Market Cap: NT$4.6b
Focuses on professional research and development, and technical material manufacturing and processing business.
1271
NT$76.00
7D
1.5%
1Y
-11.0%
Orient EuroPharma
Market Cap: NT$4.4b
A pharmaceutical company, develops and manufactures drugs worldwide.
4120
NT$50.80
7D
0.2%
1Y
2.5%
Synbio Tech
Market Cap: NT$4.2b
Manufactures and sells human healthcare products and probiotics for animals.
1295
NT$122.50
7D
-11.9%
1Y
33.9%
BRIM Biotechnology
Market Cap: NT$4.2b
A clinical-stage company, engages in the development of novel regenerative therapies to combat and cure ophthalmology and degenerative joint diseases.
6885
NT$31.85
7D
-0.9%
1Y
-31.5%
Medigen Biotechnology
Market Cap: NT$4.0b
A biopharmaceutical company, engages in the research and development of new drugs and vaccines, cytotherapy, advanced nucleic acid testing, generic drugs, aesthetic medicine, and vaccine-related products in Taiwan.
3176
NT$29.05
7D
-0.5%
1Y
-24.0%
3D Global Biotech
Market Cap: NT$3.8b
Develops medical materials for human body reconstruction in China.
6808
NT$49.00
7D
-1.7%
1Y
26.1%
Nang Kuang Pharmaceutical
Market Cap: NT$3.8b
Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.
1752
NT$37.70
7D
-2.2%
1Y
-15.1%
Maxigen Biotech
Market Cap: NT$3.7b
Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.
1783
NT$45.50
7D
-0.2%
1Y
7.1%
Senhwa Biosciences
Market Cap: NT$3.6b
A drug development company, engages in the development of new drugs and targeted agents.
6492
NT$39.90
7D
5.8%
1Y
-23.1%
Syngen BiotechLtd
Market Cap: NT$3.4b
Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.
8279
NT$124.50
7D
-0.4%
1Y
-6.4%
SYN-TECH Chem. & Pharm
Market Cap: NT$3.3b
Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.
1777
NT$74.80
7D
-0.5%
1Y
-24.1%
HeXun Biosciences
Market Cap: NT$2.9b
Engages in the research and development of stem cell and treatments in Taiwan.
6986
NT$63.20
7D
-1.7%
1Y
-16.7%
Gwo Xi Stem Cell Applied Technology
Market Cap: NT$2.9b
Develops stem cell medicines for patients with unmet medical needs.
6704
NT$30.05
7D
9.9%
1Y
-0.5%
GlycoNex Incorporation
Market Cap: NT$2.8b
Engages in the development of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan.
4168
NT$25.60
7D
-0.6%
1Y
1.2%